Login
$IPSC
$1.42 -$0.04 (2.74%) Close

Company Executives

$IPSC Management Team

Dr. Chad Cowan

Chief Scientific Officer

Age 53
Compensation -
Sex Male

Mr. Douglas Carr

Interim Chief Financial Officer

Age -
Compensation -
Sex Male

Dr. Brent Pfeiffenberger

Chairman of the Board

President

Chief Executive Officer

Age 47
Compensation $2.193M USD
Sex Male

Dr. Gregory Russotti

Chief Technology and Manufacturing Officer

Age 58
Compensation $1.488M USD
Sex Male
Directors
7
serving now
Independent
Not stated
the proxy does not say
Average tenure
3.2 years
from year joined
CEO also chairs the board
Yes
Brent Pfeiffenberger, Pharm.D.
Director Age On board Independent Committees Other public boards 2025 pay Source
Alessandro Riva, M.D.
65 2021
5 years
Not stated
Audit Compensation
BeOne Medicines, Bicycle Therapeutics, PLC $67,427
Han Lee, Ph.D., M.B.A.
45 2025
1 year
Not stated
Compensation Audit
None stated $40,241
Kimberly Blackwell, M.D.
57 2021
5 years
Not stated
Audit Nominating and Corporate Governance · Chair
Monte Rosa Therapeutics, Inc. $71,052
Martin Murphy, Ph.D.
57 2025
1 year
Not stated None stated None stated $40,335
Brent Pfeiffenberger, Pharm.D.
48 2023
3 years
Not stated None stated None stated Paid as CEO
Daphne Quimi
60 2022
4 years
Not stated
Audit · Chair Nominating and Corporate Governance
Amylyx Pharmaceuticals, Inc. $77,052
Timothy P. Walbert Leaving at the meeting
Not stated Not stated Not stated
Compensation
None stated $63,052

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

2 disclosed in the proxy filed Apr 27, 2026
executive officers
executive officers of the company
Amount not stated

Proprietary Information and Assignment (Information) Agreements entered into with all executive officers

directors and officers
directors and officers of the company
Amount not stated

Indemnification agreements with each director and officer to indemnify for expenses, judgments, fines and settlements arising from service

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support